SCHEMBL28259971

SCHEMBL28259971

Cn1ccnc1C(=O)Nc1ccc(-c2cccc3c2C=CCC3)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 1/20 0.48
▸ ROCK1 Q13464 1/20 0.48
▸ NAMPT P43490 1/20 0.47
▸ GRM1 Q13255 4/20 0.45
▸ GRM4 Q14833 6/20 0.42
▸ KDM4E B2RXH2 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ MAPT P10636 1/20 0.37
▸ BACE1 P56817 2/20 0.37
▸ F2 P00734 2/20 0.37
▸ F10 P00742 2/20 0.37
▸ PRSS1 P07477 2/20 0.37
▸ PRSS2 P07478 2/20 0.37
▸ PRSS3 P35030 2/20 0.37
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KDR P35968 2/20 0.34
▸ FLT1 P17948 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27972606 0.79 KDM4E (0.51) KDM4EPOLBMAPTNPC1RAB9A
SCHEMBL27972621 0.79 NPC1 (0.42) KDM4EPOLBMAPTF2F10
SCHEMBL27972550 0.79 GRM1 (0.43) GRM1GRM4KDM4EPOLBMAPT
SCHEMBL27972312 0.78 AVPR2 (0.45) NPC1RAB9A
SCHEMBL28866664 0.77 PTPN1 (0.52) KDM4EPOLBMAPTNPC1RAB9A
SCHEMBL27972293 0.77 RAB9A (0.54) KDM4EPOLBMAPTRAB9ASMN1; SMN2
SCHEMBL28813725 0.77 GRM1 (0.46) GRM1GRM4KDM4E
SCHEMBL27972308 0.77 MEN1 (0.50) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL28426457 0.77 CHRNB2 (0.43) POLBSMN1; SMN2
SCHEMBL27972271 0.76 RAB9A (0.53) ROCK2ROCK1KDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483423-A P2X4 receptor antagonist NIPPON CHEMIPHAR CO 2019-11-22 — — CN disclosed
CN-108863959-A P2X4 RECEPTOR ANTAGONIST 日本化学药品株式会社 2018-11-23 — — CN disclosed
Send feedback